An interventional study of Transcranial Magnetic Stimulation (TMS) in Isolated Focal Hand Dystonia, sponsored by Duke University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by Duke University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Dystonia, Focal, Task-Specific with a site in United States — 1 open to participants now, 3 under way, none of them phase 3. Dystonia, Focal, Task-Specific · United States.
Among the 21 studies in Dystonia, Focal, Task-Specific with a site in United States, this one is the only one that started in 2023, is one of 3 with no phase, and was the 19th registered.
26 studies on the registry are indexed under Dystonia, Focal, Task-Specific; 3 are open to participants now.
Browse Dystonia, Focal, Task-Specific studies →1 of the 21 studies in Dystonia, Focal, Task-Specific with a site in United States is open now. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 21–75
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 2 Dystonia, Focal, Task-Specific studies recruiting now, 1 sets no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 5
First in 2001; this study’s year is marked. 1 started in 2023.
This study's enrollment of 21 is above the median of 15 across 13 interventional studies indexed under Dystonia, Focal, Task-Specific.
Median enrollment 12 across the 9 interventional studies, 56 across the 12 observational. Of the 18 that completed or were terminated, 4 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 21 has an industry lead sponsor. The 5 most frequent:
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
Duke University has 2 studies filed under Dystonia, Focal, Task-Specific — fewer than ten, so there is no comparison to draw.
2 of the studies in Dystonia, Focal, Task-Specific with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06015672Duke UniversityAccelerated TMS for Focal Hand Dystonia | 2027-02-05 |
| NCT06367608University of Maryland, BaltimoreMRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD) | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 21 studies in Dystonia, Focal, Task-Specific with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on this, the current study administers four TMS sessions in a day, with assessments conducted in four weeks, twelve weeks, and 20 weeks after each session. The research involves 8 in-person and 6 virtual visits focused on functional MRI brain scans and writing behavior analysis. The potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in focal hand dystonia, paving the way for further advancements in clinical therapy for this condition.
The primary aim of this research is to investigate the impact of transcranial magnetic stimulation (TMS) on both brain function and behavioral outcomes among individuals suffering from focal hand dystonia. A preliminary examination of a previous TMS study carried out by our team revealed that the application of TMS, using personalized, fMRI-guided brain targeting and interleaved TMS delivery during motor tasks, has the potential to modify brain activity and ameliorate dystonic behavior after a single session of TMS in patients with focal hand dystonia. This present study seeks to build upon these promising findings by administering four TMS sessions in a single day, interspersed with four rest intervals, a protocol referred to as "accelerated TMS." The investigation will consist of a total of eight in-person appointments. Participants with focal hand dystonia will receive accelerated TMS during two in-person visits. Following each TMS session, participants will evaluate changes in brain function and behavior. During the assessment visits, individuals will undergo functional MRI brain scans and engage in writing tasks on an electronic tablet. The principal risk associated with TMS is the possibility of inducing a seizure. However, this study will strictly adhere to safety guidelines, utilizing TMS levels that have not previously been linked to seizures in properly screened individuals. Notably, the dosages of TMS proposed for use in this study have not caused seizures in healthy volunteers. To further mitigate the risk of seizures, potential subjects will undergo medical screening for any known factors that could predispose them to seizures. The primary advantage of this study lies in its potential to enhance dystonic behavior in patients with focal hand dystonia, while also deepening our comprehension of the foundational changes in brain function before and after TMS intervention for focal hand dystonia. The discoveries stemming from this investigation will pave the way for future research endeavors aimed at advancing brain stimulation as a viable clinical therapy for focal hand dystonia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received TMS sessions at primary somatosensory cortex
Device: Transcranial Magnetic Stimulation (TMS)
Participants receive TMS at a cortical target at smaller amplitude
Device: Transcranial Magnetic Stimulation (TMS)
Participants will have two accelerated transcranial magnetic stimulation (TMS) visits. Each TMS visit will be separated by 5 months. During each TMS visit, they will receive four TMS sessions, each separated by 60 minutes of rest.
Measurement of Hand Sensation using STDT
Surface skin electrodes will be placed on the index finger of the right hand of the participant. The anode will be located 0.5 cm distal to the cathode. The surface electrodes will be connected by a wire to a constant current stimulator. Participants will receive a stimulus consisting of a square-wave electrical pulse with a width of 0.2 milliseconds delivered with a constant current stimulator. A stimulation intensity will first be defined for each participant by delivering a series of stimuli at increasing intensity from 2 mA in steps of 1 mA; the intensity used for STDT will be the minimal intensity perceived by the participant in 10 of 10 consecutive stimuli. STDT will then be investigated using an ascending staircase method. Specifically, paired stimuli will be delivered to the anode and cathode skin electrodes attached to the participant's right-hand digit. The paired stimuli will be delivered starting with an interstimulus
Time frame: Baseline, 4 weeks, 12 weeks, 20 weeks, 24, weeks, 32 weeks and 40 weeks
Change in behavioral writing measure
Using change in peak accelerations to assess writing behavior
Time frame: Baseline, 4 weeks, 12 weeks, 20 weeks, 24, weeks, 32 weeks and 40 weeks
Plan to share: No
Started Dec 2023 (actual). Primary completion is estimated for Feb 2027, 37 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dystonia, Focal, Task-Specific →